COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Selective Intra-arterial Injection of PRRT in Neuroendocrine Tumor Patients With Liver Metastases

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03724409
Recruitment Status : Recruiting
First Posted : October 30, 2018
Last Update Posted : September 6, 2019
National Institutes of Health (NIH)
Holden Comprehensive Cancer Center
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Sandeep Laroia, University of Iowa